ArticleJACC. Case reports2026
Transcatheter Management of Severe Aortic Stenosis, Acute Pulmonary Embolism, and Gastrointestinal Bleeding.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe concurrent presentation of severe aortic stenosis (AS), acute pulmonary embolism (PE), and gastrointestinal bleeding creates a clinical dilemma where treating one condition may exacerbate another. CASE SUMMARY: A 72-year-old woman presented with fatigue, palpitations, and melena. She was found to have severe AS, bilateral acute PE, and a bleeding duodenal ulcer. After initial stabilization with transfusion, we used a staged multidisciplinary approach: catheter-directed thrombectomy with adjunctive balloon angioplasty for residual stenosis, followed by transfemoral transcatheter aortic valve replacement. DISCUSSION: This case illustrates the challenges of coexisting AS, gastrointestinal bleeding, and PE. Although Heyde syndrome was considered a possible unifying mechanism, absent angiodysplasia and von Willebrand factor testing preclude definitive diagnosis. A staged, physiology-driven strategy prioritized immediate threats and enabled safe definitive therapy. TAKE-HOME MESSAGES: In patients with competing thrombotic and bleeding pathologies, a staged, physiology-first approach prioritizing the most immediate threat enables safe sequential intervention. Percutaneous techniques minimize cumulative risk in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.